US Department of Justice

Teva Pharmaceuticals, Glenmark, Patent settlement, Generics, US Department of Justice

Teva and Glenmark Agree to $255M Settlement with DOJ in Price-Fixing Case

Anika Sharma

Teva and Glenmark Pharmaceuticals, implicated in a price-fixing scheme, are facing substantial penalties and divestiture mandates after reaching a deferred ...

AARP, US Department of Justice, US Chamber of Commerce, Inflation Reduction Act

AARP Backs Justice Department Against Chamber of Commerce’s Lawsuit on Medicare Drug Price Talks

Anika Sharma

A new development has emerged in the legal battle over the Inflation Reduction Act’s (IRA) provisions on prescription drug prices. ...

US Chamber of Commerce, US Department of Justice, Inflation Reduction Act, injunction, Department of Health and Human Services

Department of Justice Criticises Chamber of Commerce’s Lawsuit Against IRA’s Medicare Price Negotiations

Anika Sharma

Exactly one year has passed since President Joe Biden’s signature inked the Inflation Reduction Act (IRA) into law. In a ...

Teva’s $200M Deal to End Price-Fixing Probe

Teva sets aside $200 million in ‘advanced’ settlement negotiations to end the US price-fixing investigation

SG Tylor

Teva, a pharmaceutical company facing a price-fixing indictment by the U.S. Department of Justice (DOJ), is taking steps to resolve ...